Be-a-MedFounder
Be-a-MedFounder
Vision Vision (write your vision/product in one sentence)
Investor(s) Investor(s)
Founder(s) Founder(s)
Angel Investor(s) Angel Investor(s)
CEO CEO
Employees Employees (Write here the equivalent of full time employees)
Core Team (Angel Investors Institutional Investors)
Valuation Valuation
Accelerators Accelerators (participation in incubators and/or accelerators)
Awards Awards
Links https://angel.co/b-a-medfounder-3 https://www.facebook.com/BaMedFounder
Website http://www.bamedfounder.com/



Introduction

Be-a-MedFounder is first global crowdfunding platform dedicated to helping smaller medical device companies and inventors receive the funding they need in order to turn revolutionary ideas into actual valuable medical devices that can help people. The Be-a-MedFounder platform seeks to facilitate the funding of medical devices through investor and donor contributions from all over the world.

Many people who have ideas about creating medical devices may not have the necessary funds to develop them. Thousands of excellent ideas remain at the level of a dream and never come to fruition.

B-a-MedFounder is the brainchild of a serial entrepreneur in medical devices and an investment banker, experienced in the difficulties of starting a new entrepreneurial project and finding early funding. B-a-MedFounder was founded to give such people a virtual showroom to be visited by investors and donors who wish to provide funds to have medical device inventions and innovations developed with the intention of patients benefitting from the creation of a medically valuable device. It provides an online platform for rendering crowdfunding services to medical device entrepreneurs, investors and donors in the global medical device industry.

B-a-MedFounder Ltd. is a private, limited by shares liability company domiciled in the European Union (the Republic of Cyprus) with two principal shareholders, MedFounder International Ltd. and Me-Da Med International Ltd.


Overview via B-a-MedFounder and images via Facebook